Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dr. Kamlesh Khilnani
Comparison Study of Efficacyinvolving Intravitreal Ranibizumab Versus Standard Laser Mono Therapy in Patients With Visual Impairment Due to Diabetic Macula Edema
IOSR Journal of Dental and Medical Sciences
Related publications
Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical Ophthalmology
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Cost-Effectiveness of Ranibizumab Versus Aflibercept in the Treatment of Visual Impairment Due to Diabetic Macular Edema: A UK Healthcare Perspective
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results
Ophthalmology
Ophthalmology
Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
American Journal of Ophthalmology
Ophthalmology
Comparative Study of Intravitreal Ranibizumab With and Without Nepafenac Eye Drops for Center Involving Diabetic Macular Edema
Journal of Medical Science And clinical Research
Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema
Journal of Pharmaceutical and Scientific Innovation
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data From a Non-Interventional, Multicenter Study in Germany
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
